Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSNSE
Financial results for the period ended March 31, 2026
As filed · Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
EarningsImprovingMajormateriality 77 out of 100
What happened
FactAarey Drugs & Pharmaceuticals Limited held a board meeting on 30th May 2026 to approve the audited standalone financial results for the fourth quarter and year ended 31st March 2026, along with the audit report and a statement regarding the utilization of funds raised through convertible warrants. The trading window will reopen 48 hours after the announcement of these results. A copy of the audited financial results and audit report has been attached to the filing.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%